Cloud Banner

Pharmaceutical

Image

Global Sinusitis Treatment Drugs Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Oct 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Sinusitis Treatment Drugs Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR - 3.5% Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 3.03 Billion
Diagram Market Size (Forecast Year) USD 3.99 Billion
Diagram CAGR 3.5%

Global Sinusitis Treatment Drugs Market, By Type (Acute Sinusitis, Sub-Acute Sinusitis, Chronic Sinusitis), Treatment (Analgesics, Antihistamines, Corticosteroids, Antibiotics, Sulphonamides, Other), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Sinusitis Treatment Drugs Market

Sinusitis Treatment Drugs Market Analysis and Size

The global sinusitis treatment drugs market is expected to witness significant growth during the forecast period. The majority of sinus infections are stated to be caused by common cold and viral infections. These infections are classified as chronic and acute based on THE level of severity. Since sinus infection and COVID-19 have parallel symptoms, there is an urgent need to distinguish between the two.  Sinusitis affects approximately 40% of the U.S. population, with yearly treatment costs of $ 8.6 million. Such increasing prevalence particularly among the urban population, has been the major driving factor.

 Data Bridge Market Research analyses a growth rate in the global sinusitis treatment drugs market in the forecast period 2022-2029. The expected CAGR of g global sinusitis treatment drugs market is tend to be around 3.50% in the mentioned forecast period. The market was valued at USD 3.03 billion in 2021, and it would grow upto USD 3.99 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.       

Sinusitis Treatment Drugs Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Acute Sinusitis, Sub-Acute Sinusitis, Chronic Sinusitis), Treatment (Analgesics, Antihistamines, Corticosteroids, Antibiotics, Sulphonamides, Other), Route of Administration (Oral, Topical, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Pfizer Inc.(U.S.), Merck KGaA (Germany), Sanofi (France), Biocare Medical, LLC (U.S.), Lilly (U.S.), Teva Pharmaceutical Industries (Israel), Bristol-Myers Squibb Company (U.S.), GSK plc. (U.K.), Bayer AG (Germany), AstraZeneca (U.K.), Regeneron Pharmaceuticals Inc (U.S.), OptiNose US, Inc (U.S.)

Market Opportunities

  • Improved Intra-nasal Drug Delivery
  • Approval From Regulatory Bodies

Market Definition

Sinusitis is also known as sinus infection and it is a condition wherein the tissues lines the sinuses became inflamed or swelled. It is mostly triggered by common cold or allergies. Symptoms include nasal congestion, headache or facial pain, rhinorrhea and others. Facial pain in sinusitis is the most common symptom. Acute sinusitis generally is caused by virus and effective method of treatment were nasal irrigation. For chronic sinusitis, patients were recommended with antibiotics, topical and corticosteroids, and other medications.  

Global Sinusitis Treatment Drugs Market Dynamics

Drivers

  • Increasing Prevalence of Sinusitis

The incidence of sinus infection among adults and children is rising. Among the most common of triggering sinus infection in adults is the history of respiratory tract infections, compromised immunity, structural issues in sinuses, and nasal polyps. Sinusitis can be caused in children by using a pacifier, a day-care, feeding while lying down, and second-hand contact to smoke. Thus, the increasing occurrence of sinusitis is boosting the growth of the sinusitis treatment drugs market.

  • High Demand for nasal sprays

The unique nasal spray designs are a fast rising phenomenon in the global sinusitis treatment drugs market. Innovators are gaining attentiveness that investors need to go beyond drug innovations and focus more on different ways to deliver it in hard-to-reach cavities of the patients’ sinuses. For instance, the Optinose XHANCE is gaining approval for overcoming this challenge and developing a nasal spray that patients can use at the comfort of their home. 

Opportunities

  • Improved Intra-nasal Drug Delivery

The high incidence of sinusitis in the U.S. is creating beneficial revenue opportunities for companies in the sinusitis treatment drugs market. For instance, Nasus Medical, a startup born out of Stanford Biodesign and now a Fogarty Institute Company is building incremental opportunities by developing a solution for improved intra-nasal drug delivery. Major market players are taking advantages from such innovations to develop new advanced devices that allow patients to treat themselves at home to diminish symptoms of sinusitis in its early stages. This improves the quality of life of patients. This creates more opportunity for the market growth.

  • Approval From Regulatory Bodies

Rising recommendation from regulatory bodies for approval of the new drug used in the treatment of nasal polyps, is expected to drive the growth of global sinusitis treatment drugs market, over the forecast period. For instance, In Aug 2020, Xolair from Novartis received approval from the European Commission in the form of an add-on therapy along with corticosteroids for treating chronic rhinosinusitis with the nasal polyps. In addition to this, in Aug 2020, Satsuma Pharmaceuticals, Inc. declared initiation on the part of enrolment of patients in ASCEND trial. It is a multi-centre, 12-month, open-label study for assessing tolerability and safety of STS101.

 Restraints/Challenges

  • Lack of skilled professionals

The lack of qualified healthcare professionals who are unable to treat these patients with appropriate treatments could curb the growth of the global sinusitis treatment drugs market over a forecast period.

  • High Cost

The huge expenditure associated with the treatment of sinusitis hamper the market growth as it involves the high-end drug types such as analgesics, antihistamines, corticosteroids.  

This global sinusitis treatment drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global sinusitis treatment drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Sinusitis Treatment Drugs Market

Sinus infection and COVID-19 have parallel symptoms, thus there is a need to distinguish between the two. Investors in the sinusitis treatment market are surging awareness that coronavirus is related with some of the major symptoms such as dry cough, whereas sinus is linked with cough involving mucus. As such, there is not enough evidence whether COVID-19 causes sinusitis.

The symptoms of sinus overlap with that of COVID-19, shareholders in the sinusitis treatment market are growing awareness about telemedicine and e-health to decrease the load on healthcare professionals and reduce clinical visits. Digital consultations are mounting rapidly among individuals living in urban cities. Investors in the value chain are drawing future growth opportunities in telemedicine to increase its penetration in rural regions.

Global Sinusitis Treatment Drugs Market Scope

The global sinusitis treatment drugs market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Acute Sinusitis
  • Sub-Acute Sinusitis
  • Chronic Sinusitis

Treatment

  • Analgesics
  • Antihistamines
  • Corticosteroids
  • Antibiotics
  • Sulphonamides
  • Other

Route of Administration

  • Oral
  • Topical
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Sinusitis Treatment Drugs Market Regional Analysis/Insights

The global sinusitis treatment drugs market is analysed and market size insights and trends are provided by type, treatment,  route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global sinusitis treatment drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing a positive growth for global sinusitis treatment drugs market throughout the forecasted period due to the increasing awareness about the diseases and rapid growth in bacterial as well as viral diseases.

North America dominates the market due to the high-income of the countries, vulnerable sinusitis population and advanced healthcare facilities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Sinusitis Treatment Drugs Market Share Analysis

The global sinusitis treatment drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global sinusitis treatment drugs market

Key players operating in the global sinusitis treatment drugs market include:

  • Pfizer Inc.(U.S.)
  • Merck KGaA (Germany)
  • Sanofi (France)
  • Biocare Medical, LLC (U.S.)
  • Lilly (U.S.)
  • Teva Pharmaceutical Industries (Israel)
  • Bristol-Myers Squibb Company (U.S.)
  • GSK plc. (U.K.)
  • Bayer AG (Germany)
  • AstraZeneca (U.K.)
  • Regeneron Pharmaceuticals Inc (U.S.)
  • OptiNose US, Inc (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Sinusitis Treatment Drugs Market is projected to grow at a CAGR of 3.50% during the forecast period by 2029.
The future market value of the Sinusitis Treatment Drugs Market is expected to reach USD 3.99 billion by 2029.
The major players in the Sinusitis Treatment Drugs Market are Pfizer Inc.(U.S.), Merck KGaA (Germany), Sanofi (France), Biocare Medical, LLC (U.S.), Lilly (U.S.), Teva Pharmaceutical Industries (Israel), Bristol-Myers Squibb Company (U.S.), GSK plc. (U.K.), Bayer AG (Germany), AstraZeneca (U.K.), Regeneron Pharmaceuticals Inc (U.S.), OptiNose US, Inc (U.S.)
The country covered in the Sinusitis Treatment Drugs Market are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials